Novartis bags Gilenya EC approval for multiple sclerosis in young patients

pharmanewsdaily- December 2, 2018 0

Gilenya EC approval : The European Commission (EC) has expanded the approval of Novartis multiple sclerosis drug Gilenya (fingolimod) to include the treatment of both ... Read More

Sanofi strikes $805m deal with Principia Biopharma for multiple sclerosis drug development

pallavi123- November 12, 2017 0

Sanofi and Principia Biopharma have announced a significant partnership to develop and commercialize PRN2246, a promising oral drug candidate for multiple sclerosis (MS) and other ... Read More

FDA approves Genentech’s Ocrevus for multiple sclerosis treatment

pharmanewsdaily- April 2, 2017 0

In a landmark decision, the US Food and Drug Administration (FDA) has granted approval to Genentech, a subsidiary of the Roche Group, for its multiple ... Read More